Cuu Long Pharmaceutical JSC (HOSE: DCL)

DCL Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jan 1, 2021	Jan 1, 2020
Cash & Equivalents	18,026	23,517	52,852	41,255	41,878	14,499
Short-Term Investments	109,354	-	14,000	446,623	877,876	838,255
Trading Asset Securities	104,795	94,795	94,795	70,270	-	-
Cash & Short-Term Investments	232,175	118,312	161,647	558,148	919,754	852,754
Cash Growth	1.23%	-26.81%	-71.04%	-39.32%	7.86%	28.60%
Accounts Receivable	285,293	272,178	224,627	176,980	168,394	200,401
Other Receivables	413,409	431,418	444,704	134,123	41,393	70,037
Receivables	698,702	703,596	669,332	311,103	209,787	270,438
Inventory	416,331	365,031	315,080	308,196	226,988	227,082
Prepaid Expenses	2,826	2,522	1,709	1,660	3,741	3,613
Other Current Assets	145,378	213,663	274,478	82,048	81,948	22,732
Total Current Assets	1,495,412	1,403,124	1,422,245	1,261,155	1,442,218	1,376,618
Property, Plant & Equipment	880,603	834,368	649,459	491,030	325,499	302,607
Long-Term Investments	-	-	-	-	1,000	1,000
Other Intangible Assets	23,347	23,316	20,984	21,151	21,366	21,474
Long-Term Deferred Tax Assets	4,237	4,881	5,932	2,421	3,753	2,381
Other Long-Term Assets	11,897	11,770	6,703	5,271	6,570	8,391
Total Assets	2,415,497	2,277,460	2,105,323	1,781,028	1,800,407	1,712,471
Accounts Payable	127,107	66,129	36,751	31,117	26,721	40,535
Accrued Expenses	37,461	46,175	51,674	30,943	32,908	28,851
Short-Term Debt	362,602	349,732	288,008	361,270	240,662	218,796
Current Portion of Long-Term Debt	55,474	51,646	62,406	32,466	21,316	21,316
Current Portion of Leases	24,041	20,758	3,580	-	-	-
Current Income Taxes Payable	8,120	14,908	12,558	5,681	17,925	14,068
Current Unearned Revenue	-	-	-	-	730.92	-
Other Current Liabilities	58,438	68,726	99,090	249,752	3,318	3,080
Total Current Liabilities	673,243	618,075	554,068	711,229	343,581	326,647
Long-Term Debt	259,952	208,593	159,598	106,561	485,617	499,834
Other Long-Term Liabilities	-	-	-	-	213.9	1,568
Total Liabilities	933,195	826,668	713,666	817,790	829,411	828,049
Common Stock	730,410	730,410	730,410	588,328	568,328	568,328
Additional Paid-In Capital	220,359	220,359	220,359	7,236	-	-
Retained Earnings	512,793	481,561	422,844	316,282	301,709	237,093
Comprensive Income & Other	20.17	20.17	20.17	20.17	31,486	31,486
Total Common Equity	1,463,582	1,432,350	1,373,633	911,866	901,522	836,906
Minority Interest	18,720	18,441	18,024	51,372	69,473	47,516
Shareholders' Equity	1,482,302	1,450,792	1,391,657	963,238	970,995	884,422
Total Liabilities & Equity	2,415,497	2,277,460	2,105,323	1,781,028	1,800,407	1,712,471
Total Debt	702,069	630,730	513,592	500,297	747,595	739,945
Net Cash (Debt)	-469,894	-512,418	-351,945	57,851	172,159	112,809
Net Cash Growth	-	-	-	-66.40%	52.61%	-
Net Cash Per Share	-6433.29	-7015.48	-5016.29	1006.12	3029.22	1495.80
Filing Date Shares Outstanding	73.04	73.04	73.04	58.83	56.83	56.83
Total Common Shares Outstanding	73.04	73.04	73.04	58.83	56.83	56.83
Working Capital	822,169	785,049	868,177	549,927	1,098,637	1,049,971
Book Value Per Share	20037.81	19610.21	18806.32	15499.27	15862.71	14725.76
Tangible Book Value	1,440,235	1,409,034	1,352,649	890,715	880,156	815,433
Tangible Book Value Per Share	19718.17	19291.00	18519.03	15139.76	15486.76	14347.92
Buildings	181,452	181,452	181,452	184,154	120,901	120,168
Machinery	703,724	702,704	693,570	710,381	548,773	547,306
Construction In Progress	480,941	416,779	206,222	25,712	50,986	5,170

Source: S&P Capital IQ. Standard template. Financial Sources.